ArticleInfectious diseases of poverty2025
Evaluating Thailand's malaria reactive surveillance and response strategies for malaria elimination: a mixed-method study.
Article in Infectious diseases of poverty, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Strengthening the health systems at national level for malaria elimination in the Greater Mekong Subregion countries: a qualitative study.Infectious diseases of poverty · 2026Article
- Epidemiology of malaria and leishmaniasis in Thailand (2004-2025): A systematic review.Current research in parasitology & vector-borne diseases · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThailand aims to eliminate malaria in all provinces by 2030, where 37 out of 77 provinces have been verified as malaria-free by 2021. Thailand is accelerating its elimination activities and preventing re-establishment of malaria through implementation of the 1-3-7 reactive surveillance and response (RASR) strategy, which entails case notification within one day, case investigation within three days and case investigation survey within seven days after detecting an index malaria case. This study aimed to assess how this 1-3-7 malaria RASR strategy was implemented to understand how it may be optimised to achieve national malaria elimination goals.
methodsA cross-sectional mixed-method study was conducted in Tak, Songkhla and Yala provinces of Thailand between January and April 2023. Quantitative survey with purposively recruited malaria programme stakeholders (n = 33) and frontline malaria service providers (FMSPs) (n = 41), qualitative focus group discussions with malaria programme stakeholders, FMSPs and mobile migrant population, and individual in-depth interviews with malaria programme stakeholders were conducted face-to-face in Thai language. Quantitative and qualitative data were analysed descriptively and thematically.
resultsAbout half of survey participants (40/74, 54.1%) perceived that malaria cases were notified within the specified one day timeframe. Almost all participants (73/74, 98.7%) reported that case investigation, focus investigation and response activities were conducted within the required timeframes, except in border areas where malaria burden was high. Despite every participant (74/74, 100.0%) being aware of and considering the 1-3-7 strategy as efficient, challenges such as limited human resources and budget, low levels of community participation, and difficult terrain and telecommunication were reported in performing RASR activities.
conclusionsThe overall implementation of RASR activities was reported to be timely except for malaria case notification and focus response activities in border areas. Despite good acceptability towards RASR activities, the 1-3-7 strategy is not a one-size-fits-all approach; its feasibility for implementation depends on health system capacity and malaria incidence of the area. There are still several challenges to be addressed particularly for successful implementation of RASR activities for cross-border malaria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.